Global BioAccess Fund

VC · New York (United States)

VC

Seed

Series A

Sign up free to access full profile and submit your pitch.

About

Global BioAccess Fund is a venture capital firm specializing in series A to series C, early stage and growth capital investments. The firm seeks to invest in transformative technologies that address unmet needs in oncology, cardiovascular, CNS, clinical-stage development, therapeutics, life sciences and devices companies. The firm primarily invest in the United States. The firm invest up to $10 million. Global BioAccess Fund is based in New York, New York.

Investment Criteria

Other investors that have backed the same portfolio companies as Global BioAccess Fund. Expand any entry to see the shared portfolio companies.

• Catalio Capital Management

  2 shared

  Shared portfolio companies

  • Cartography Biosciences, Inc.
  • Odyssey Therapeutics, Inc.
• Norwest Venture Partners

  2 shared

  Shared portfolio companies

  • Nuvig Therapeutics, Inc.
  • ShiraTronics, Inc.
• Novo Holdings

  2 shared

  Shared portfolio companies

  • Acesion Pharma ApS
  • Nuvig Therapeutics, Inc.
• 8VC

  1 shared

  Shared portfolio companies

  • Cartography Biosciences, Inc.
• a16z

  1 shared

  Shared portfolio companies

  • Cartography Biosciences, Inc.
• Agent Capital

  1 shared

  Shared portfolio companies

  • Vittoria Biotherapeutics, Inc.
• AlbionVC

  1 shared

  Shared portfolio companies

  • Epsilogen Ltd
• Amgen Ventures

  1 shared

  Shared portfolio companies

  • Cartography Biosciences, Inc.
• Amzak Capital Management

  1 shared

  Shared portfolio companies

  • ShiraTronics, Inc.
• Artis Ventures (AV)

  1 shared

  Shared portfolio companies

  • Cartography Biosciences, Inc.